TABLE 4.
Effects of access and free access to a broad contraceptive method mix
| (1) | (2) | (3) | |
|---|---|---|---|
| All women | Current contraceptive users | ||
| Modern Contraceptive Use | LARC Use | Decision-Making | |
| Access to both LARC and SARC | 0.021 [−0.007,0.049] |
0.055 [−0.007,0.116] |
0.014 [−0.020,0.049] |
| Free access to both LARC and SARC | 0.047** [0.019,0.074] |
0.004 [−0.055,0.062] |
0.014 [−0.020,0.047] |
| p-value | 0.004 | 0.027 | 0.663 |
| Control mean | 0.252 | 0.282 | 0.906 |
| Number of observations | 29802 | 8462 | 8462 |
95% confidence intervals in brackets
LARC: long-acting reversible contraceptives, including implants and intrauterine devices. SARC: short-acting reversible contraceptives. Decision-making: whether respondent participated in the decision on contraceptive method. Propensity weights generated from multinomial logistic models were applied to adjust for observed differences by treatment status. The p-value row reports the two-sided p-value from an F-test of equality of the treatment effects of access and free access.
p < 0.05,
p < 0.01,
p < 0.001